Related Experiment Videos
Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study
Insights
Myocardial norepinephrine levels vary in heart disease patients. Lower norepinephrine in dilated cardiomyopathy correlates with heart failure severity, while hypertrophic cardiomyopathy shows varied concentrations.
Area of Science:
- Cardiology
- Biochemistry
- Pharmacology
Background:
- Catecholamines, such as norepinephrine and epinephrine, play crucial roles in cardiac function.
- Alterations in myocardial catecholamine levels are implicated in various cardiomyopathies and heart diseases.
- Accurate measurement of catecholamines in small myocardial biopsy samples is essential for understanding cardiac pathophysiology.
Purpose of the Study:
- To determine myocardial norepinephrine and epinephrine concentrations in patients with dilated cardiomyopathy, hypertrophic cardiomyopathy, and other heart diseases.
- To assess the validity of using small myocardial biopsy specimens for catecholamine analysis.
- To investigate the correlation between myocardial catecholamine levels and disease severity or characteristics.
Main Methods:
- High-performance liquid chromatography (HPLC) was employed for catecholamine determination.
- Myocardial biopsy specimens (2-6 mg) were obtained from the right or left ventricle during cardiac catheterization.
- 45 patients with various cardiac conditions (dilated cardiomyopathy, hypertrophic cardiomyopathy, other heart diseases) were included, yielding 66 biopsy specimens.
Main Results:
- Myocardial norepinephrine concentrations were inversely correlated with hypertrophy grade in congestive cardiomyopathy and other heart diseases, but not hypertrophic cardiomyopathy.
- Left ventricular norepinephrine levels were consistently lower than right ventricular levels within the same patient.
- Some hypertrophic cardiomyopathy cases exhibited exceptionally high norepinephrine levels; dilated cardiomyopathy patients sometimes showed lower levels than expected for fibrosis and heart failure severity.
- Plasma norepinephrine and epinephrine levels were significantly elevated in dilated cardiomyopathy patients.
Conclusions:
- Myocardial catecholamine levels can be reliably assessed using small biopsy samples.
- Norepinephrine concentrations show differential correlations with hypertrophy and ventricular location in different heart conditions.
- Elevated plasma catecholamines are characteristic of dilated cardiomyopathy, suggesting sympathetic nervous system activation.
Abstract:
A high performance liquid chromatographic method was used to determine myocardial norepinephrine and epinephrine concentrations in 66 biopsy specimens obtained from the right or left ventricle during routine diagnostic cardiac catheterization of 45 patients with dilated (congestive) or hypertrophic cardiomyopathy, or with heart disease other than cardiomyopathy, such as acute perimyocarditis, postmyocarditis and constrictive pericarditis. The validity of catecholamine determination in a 2 to 6 mg biopsy specimen to assess overall ventricular myocardial catecholamines was demonstrated. Norepinephrine concentrations in the myocardium were inversely correlated with the grade of hypertrophy in patients with congestive cardiomyopathy or heart disease other than cardiomyopathy, but not in patients with hypertrophic cardiomyopathy. The fact that the myocardial norepinephrine concentration was always lower in the left than in the right ventricle of the same patient may be explained by the simple dilution of sympathetic nerve endings in the left ventricle. There were some cases of hypertrophic cardiomyopathy in which the concentration of myocardial norepinephrine was exceptionally high, although its mean value was not significantly higher than that in patients with other types of heart disease who served as a control group without cardiomyopathy. Some patients with dilated cardiomyopathy had lower levels of myocardial norepinephrine than would be expected for the degree of interstitial fibrosis and the severity of heart failure. The mean plasma norepinephrine and epinephrine levels were significantly elevated in patients with dilated cardiomyopathy.